Whitehawk Therapeutics earnings were -$63.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest WHWK earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$18.3M, up 45.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, WHWK reported annual earnings of -$63.7M, with -3.2% growth. The next WHWK earnings date is May 6, 2025.
Whitehawk Therapeutics Earnings Reports & History FAQ
What were Whitehawk Therapeutics's earnings last quarter?
On WHWK's earnings call on Invalid Date, Whitehawk Therapeutics (NASDAQ: WHWK) reported Q4 2024 earnings per share (EPS) of -$0.68, up 13.33% year over year. Total WHWK earnings for the quarter were -$18.27 million. In the same quarter last year, Whitehawk Therapeutics's earnings per share (EPS) was -$0.60.
The next WHWK earnings date is Invalid Date. Add WHWK to your watchlist to be reminded of Whitehawk Therapeutics's next earnings date.
Is Whitehawk Therapeutics profitable or losing money?
As of the last Whitehawk Therapeutics earnings report, Whitehawk Therapeutics is currently losing money. Whitehawk Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$63.69 million, a 3.15% decrease year over year.
What was WHWK's earnings growth in the past year?
As of Whitehawk Therapeutics's earnings date in Invalid Date, Whitehawk Therapeutics's earnings has grown year over year. WHWK earnings in the past year totalled -$63.69 million.
What are Whitehawk Therapeutics's earnings expectations?
The current EPS estimate for Whitehawk Therapeutics's earnings report in Invalid Date is -$0.64.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.